IPHARMA CRO has announced the initiation of two clinical trials to evaluate the efficacy of Favipiravir and Elsulfavirine on patients with COVID-19 (novel coronavirus) today.

These randomized, open-label, multicenter studies will enroll approximately 330 and 60 patient...


On 30-31th of July IPHARMA took part as a partner in a conference “Coordinates in medicine”. The conference was hold at the basis of Moscow international medical cluster in Skolkovo.

The goal of the conference was the presentation of the best practices of quality contro...


The 30th anniversary international meeting of representatives of the pharmaceutical industry will be held in Basel, Switzerland, this week. This year, on the request of participants, organizers separated a special session about drug registration in Russia and the EAEU.



On April 17-19th, 2018, the 30th anniversary international meeting of  representatives of the pharmaceutical industry will be held in Basel, Switzerland.

This year, all DIA meetings in Europe, USA, India, China and Japan will be held with an active participation of a pa...


In February, IPHARMA was authorized by the Ministry of Healthcare of the Russian Federation to conduct the Phase I clinical study of the medicinal product Avirus.

HCV-AVRS-01: Double-blind, randomized, placebo-controlled study to evaluate safety, tolerability and pharma...


On February 9th, the live part of the advanced training in Biostatistics was held at the faculty of Industrial pharmacy of the Sechenov University. This year, the audience was quite diverse: representatives of pharmacological companies, researchers from accredited medi...


IPHARMA got two Ministry of Health approvals for clinical trials conduction at once in December:

  • Phase III clinical study of the medical product OKITASK (Ketoprofen lysine salt)

  • Phase I clinical study of the medical product BI-MAB-03 (Transtusumab)

Medical pr...


The Quality Assurance Forum began its work in June 2017. This Forum assembled quality assurance experts in pharmaceutical industry for the exchange of experience and mutual support.

The first meeting of the Forum participants will be held on December 14, 2017.



On November 14-15, the 6th International Forum "Clinical trials in Russia" of the Adam Smith Institute was held in Moscow. IPHARMA was one of the major sponsors of the conference.

This year, a large pool of interesting speakers including representatives of the Federal S...

Older news >

Please reload

Please reload

Please reload

© 2020 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon